Search clinical trials for: Placebo Eflornithine Topical

Total 55392 results

Walter Reed National Military Medical Center

Terminated

Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial

Pseudofolliculitis Barbae

United States
Drugs for Neglected Diseases
Swiss Tropical & Public Health Institute; Ministry of Public Health, Democratic...

Completed

Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase (NECT-FIELD)

Human African Trypanosomiasis

Congo
LEO Pharma

Completed

Body PSOriasis: Long-term Relapse CONTROL (PSO-CONTROL)

Psoriasis Vulgaris

Russian Federation
SWOG Cancer Research Network
National Cancer Institute (NCI); Cancer Prevention Pharmaceuticals, Inc.

Active, not recruiting

S0820, Adenoma and Second Primary Prevention Trial (PACES)

Colorectal Neoplasms

United States
Stanford University
University of Pennsylvania; University of California, Davis; Oregon Health and... and other collaborators

Recruiting

Descemet Endothelial Thickness Comparison Trial I (DETECT I)

Fuchs

United States
Taro Pharmaceuticals USA

Completed

Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study

Onychomycosis

United States
Medical University of Silesia

Completed

Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD

Cannabis | Myofascial Pain | Temporomandibular Disorder | Electromyography

Poland
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Glia, LLC

Completed

Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel

Contact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein Staining

United States
Taro Pharmaceuticals USA

Completed

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

Scalp Psoriasis

United States
Integrative Skin Science and Research
Sytheon Ltd.

Completed

The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties

Human Microbiome

United States
Glia, LLC
ORA, Inc.

Completed

Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT.

Chronic Ocular Graft-versus-host Disease

United States
Orbus Therapeutics, Inc.

Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma

Glioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, IDH-wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

United States
AOTI Ltd.

Terminated

Evaluation of Topical Wound Oxygen (two2) Therapy

Diabetic Ulcer

United States, Canada
Amazentis SA
proDERM GmbH

Completed

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Skin Aging

Germany
Amazentis SA
proDERM GmbH

Completed

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

Erythema | Skin Inflammation | Sun Damaged Skin

Germany
Lakewood-Amedex Inc
PrimeVigilance; Professional Education and Research Institute

Terminated

Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer

Chronic Diabetic Foot Ulcers

United States
Thomas E. Ahlering
National Cancer Institute (NCI)

Completed

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Prostate Cancer

United States
PharmaDax Inc.
Glia, LLC

Enrolling by invitation

Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study

Keratoconjunctivitis Sicca | Dry Eye Syndrome

Taiwan
University of Sao Paulo

Recruiting

Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis

Rhinosinusitis Chronic

Brazil
University of Alabama at Birmingham
National Cancer Institute (NCI)

Completed

Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy

Prostate Cancer

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas (PREVENT)

Vitiligo

France
Aria Aesthetics Inc.

Completed

The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage

Rosacea | Acne Vulgaris | Seborrheic Dermatitis | Atopic Dermatitis

United States
Al-Azhar University

Unknown

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Skin Diseases | Breast Cancer | Skin Cancer

Egypt, Saudi Arabia
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Cancer Prevention Pharmaceuticals, Inc.

Active, not recruiting

Chemoprevention of Gastric Carcinogenesis

Gastric Cancer | Gastric Intestinal Metaplasia

Honduras, Puerto Rico
Prism Pharma Co., Ltd.

Completed

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

Systemic Scleroderma

United States
University Hospital, Clermont-Ferrand

Recruiting

Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis. (OROSOL)

Oral Mucositis

France
ParaPRO LLC
Concentrics Research

Completed

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

Scabies

United States
ParaPRO LLC
Concentrics Research

Completed

Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

Scabies

United States
Pfizer

Completed

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

Healthy

United States
Montefiore Medical Center
Duke University

Completed

Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers

Sickle Cell Disease

United States
Krystal Biotech, Inc.

Completed

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB (GEM-3)

Dystrophic Epidermolysis Bullosa | Recessive Dystrophic Epidermolysis Bullosa | Dominant Dystrophic Epidermolysis Bullosa

United States
Assuta Hospital Systems

Completed

Evaluation of a Topical Treatment for Actinic Keratosis

Actinic Keratosis of Face and Scalp

Israel
Berg, LLC

Completed

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

Superficial Basal Cell Carcinoma

United States
The Center for Clinical and Cosmetic Research
Afecta Pharmaceuticals

Completed

A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis (AFX5931)

Hand Dermatitis

United States
Dermata Therapeutics

Active, not recruiting

DMT310-005 Topical in the Treatment of Acne Rosacea

Acne Rosacea

United States
University of Alabama at Birmingham
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

Non-melanoma Skin Cancer

United States
Sir Charles Gairdner Hospital

Unknown

Topical Magnesium and Muscle Cramps in Dialysis Patients.

Chronic Kidney Diseases | End Stage Renal Disease | Dialysis Related Complications
Eli Lilly and Company

Completed

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

Skin Diseases | Skin Diseases, Genetic | Dermatitis | Eczema | Dermatitis, Atopic

Japan
Kalypsys, Inc.

Completed

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

Neuropathic Pain | Herpes Zoster | Postherpetic Neuralgia | Shingles

United States
Eli Lilly and Company
Incyte Corporation

Completed

A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis (BREEZE-AD7)

Atopic Dermatitis

Spain, Australia, Korea, Republic of, Poland, Italy, Germany, Argentina, Austria, Japan, Taiwan
National Institute of Neurological Disorders and...

Terminated

Acetyl Hexapeptide-8 for Blepharospasm

Focal Dystonia

United States
National Cancer Institute (NCI)

Completed

Eflornithine in Treating Patients With Bladder Cancer

Bladder Cancer

United States
Pharmanutra S.p.a.
NEA Clinical S.r.l.

Active, not recruiting

CETI-ANKLE: Cetilar®️ in Patients With Ankle Injury or Chronic Trauma to the Ankle

Ankle Injury or Chronic Trauma to the Ankle

Georgia, Italy
Eli Lilly and Company
Dermira, Inc.

Completed

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)

Atopic Dermatitis

United States, Canada, Germany, Poland
Cancer Prevention Pharmaceuticals, Inc.

Withdrawn

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Familial Adenomatous Polyposis
Eli Lilly and Company
Dermira, Inc.

Recruiting

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis (ADorable-1)

Eczema | Atopic Dermatitis

United States, Taiwan, Spain, Australia, Mexico, Canada, Germany, Japan, Brazil, Argentina, Poland, Czechia, France
Allergan

Completed

Evaluation of Eflornithine on Facial and Forearm Skin

Hirsutism
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
Vyne Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

Impetigo

Israel

Search clinical trials for: Placebo Eflornithine Topical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations